StraightFrom® Whole Blood REAlease® Anti-TCRγ/δ MicroBead Kit, human

The StraightFrom Whole Blood REAlease Anti-TCRγ/δ MicroBead Kit, human was developed for rapid positive selection of TCRγ/δ+ T cells directly from whole blood. No sample preparation is required, including density gradient centrifugation or erythrocyte lysis. The purified target cells are bead-free, practical for consecutive magnetic isolations, and can be label-free so that epitopes are available for any downstream application.

qualityAssuranceSatisfaction
guaranteed
more »

Related products for StraightFrom® Whole Blood REAlease® Anti-TCRγ/δ MicroBead Kit, human

Product data and images for StraightFrom® Whole Blood REAlease® Anti-TCRγ/δ MicroBead Kit, human
Figure 1

TCRγ/δ+ T cells were isolated from whole blood using the StraightFrom Whole Blood REAlease Anti-TCRγ/δ MicroBead Kit, human and Whole Blood Columns. Cells were fluorescently stained with the TCRγ/δ Antibody-FITC, CD3-APC, and Biotin Antibody-APC and analyzed by flow cytometry using the MACSQuant X. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide fluorescence.

The TCRγ/δ+ T cell content of the isolated fraction is typically 97% ± 2 (mean ± SD) for whole blood.

Figure 2

The efficient removal of all labels was shown by using Biotin Antibody-APC to analyze the cells by flow cytometry for the presence of REAlease Biotin Complex. Directly after isolation, the cells showed staining of biotin (MicroBead-free TCRγ/δ+ T cells), whereas the label-free TCRγ/δ+ T cells after the REAlease Biotin Complex release were negative for biotin similar to the non-labeled cells before separation.

Specifications for StraightFrom® Whole Blood REAlease® Anti-TCRγ/δ MicroBead Kit, human
Overview

The StraightFrom Whole Blood REAlease Anti-TCRγ/δ MicroBead Kit, human was developed for rapid positive selection of TCRγ/δ+ T cells directly from whole blood. No sample preparation is required, including density gradient centrifugation or erythrocyte lysis. The purified target cells are bead-free, practical for consecutive magnetic isolations, and can be label-free so that epitopes are available for any downstream application.

Detailed product information
Detailed separation procedure

TCRγ/δ+ T cells are labeled with StraightFrom Whole Blood REAlease Anti-TCRγ/δ-Biotin, human (REAlease Biotin Complex). Subsequently, StraightFrom Whole Blood REAlease Anti-Biotin MicroBeads (Anti-TCRγ/δ, human) bind to REAlease Biotin Complex. Then, the cell suspension is loaded onto a MACS Column, which is placed in the magnetic field of a MACS Separator. The magnetically labeled cells are retained within the column. The unlabeled non-target cells flow through; this cell fraction is thus depleted of TCRγ/δ+ T cells. Using the REAlease Bead Release Reagent, which removes the MicroBeads from the cell, target cells are eluted within the magnetic field. Finally, during the subsequent incubation with the REAlease Release Reagent, the REAlease Biotin Complex monomerizes and dissociates from the cell surface leaving the cells free of all labels.

Applications

Isolation of TCRγ/δ+ T cells from whole blood. The purified TCRγ/δ+ T cells are well suited for further flow cytometric, functional or molecular analysis.

Columns

Whole Blood columns, Multi-24 Whole Blood Column Block

You have previously chosen International as your location.
What do you want to do?